Strata Skin Sciences (SSKN) Competitors

Strata Skin Sciences (NASDAQ:SSKN) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Which has more volatility and risk, SSKN or DRIO?

Strata Skin Sciences has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Is SSKN or DRIO more profitable?

Strata Skin Sciences has a net margin of -35.13% compared to DarioHealth's net margin of -162.73%. DarioHealth's return on equity of -65.89% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.13%	-266.94%	-32.66%
DarioHealth	-162.73%	-65.89%	-39.03%

Do analysts prefer SSKN or DRIO?

Strata Skin Sciences presently has a consensus price target of $6.00, suggesting a potential upside of 232.41%. DarioHealth has a consensus price target of $40.00, suggesting a potential upside of 303.02%. Given DarioHealth's higher probable upside, analysts plainly believe DarioHealth is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
DarioHealth	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Which has better valuation and earnings, SSKN or DRIO?

Strata Skin Sciences has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$33.56M	0.22	-$10.09M	-$2.84	-0.64
DarioHealth	$27.04M	0.83	-$42.75M	-$13.20	-0.75

Do institutionals & insiders hold more shares of SSKN or DRIO?

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 39.0% of Strata Skin Sciences shares are owned by insiders. Comparatively, 11.2% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the media prefer SSKN or DRIO?

In the previous week, Strata Skin Sciences had 8 more articles in the media than DarioHealth. MarketBeat recorded 10 mentions for Strata Skin Sciences and 2 mentions for DarioHealth. DarioHealth's average media sentiment score of 0.48 beat Strata Skin Sciences' score of 0.21 indicating that DarioHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Strata Skin Sciences	0 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Strata Skin Sciences beats DarioHealth on 9 of the 16 factors compared between the two stocks.